- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05769166
Prevalence Of Deleterious Oral Habits Among a Group of School Children in Cairo, Egypt: Cross-Sectional Study (ACU333)
March 3, 2023 updated by: Mennat Allah Ashraf A.Elsabour, Ahram Canadian University
This study aims to detect the prevalence of practicing oral habits among a group of school children in Cairo, Egypt.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
An online questionnaire utilizing the third domain of Nordic Orofacial Test screen will be distributed among school children (aged five to seven years) parents to measure the prevalence of oral habits.
Study Type
Observational
Enrollment (Anticipated)
1500
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 7 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
school children aged from five to seven years
Description
Inclusion Criteria:
- school children
- accept to participate
- children within the age group
Exclusion Criteria:
- special health care needs children
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
School children
school children aged from five to seven years
|
its a questionnaire which the parent will answer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
oral habits (presence / absence)
Time Frame: baseline record
|
practicing one or more of the following habit(s): sucking habits, nail biting, bruxism
|
baseline record
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2023
Primary Completion (Anticipated)
May 1, 2023
Study Completion (Anticipated)
May 1, 2023
Study Registration Dates
First Submitted
March 3, 2023
First Submitted That Met QC Criteria
March 3, 2023
First Posted (Actual)
March 15, 2023
Study Record Updates
Last Update Posted (Actual)
March 15, 2023
Last Update Submitted That Met QC Criteria
March 3, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ACU 333
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bruxism
-
Damascus UniversityCompletedNocturnal BruxismSyrian Arab Republic
-
University of California, San FranciscoWithdrawn
-
University of Nove de JulhoUnknown
-
Universidade Federal do Rio de JaneiroUnknown
-
Karabuk UniversityRecruiting
-
Riyadh Colleges of Dentistry and PharmacyUnknownNocturnal BruxismSaudi Arabia
-
Dominik EttlinMerz PharmaceuticalsNot yet recruiting
-
Federal University of PelotasUnknown
-
CES UniversityNot yet recruitingSleep Bruxism, Childhood
-
Aydin Adnan Menderes UniversityCompleted
Clinical Trials on thired domain of nordic orofcial test-screen
-
Ahram Canadian UniversityNot yet recruitingSmoking | Orofacial Dysfunction
-
University Hospital, Basel, SwitzerlandCompletedDysphagiaSwitzerland
-
California State University, Long BeachNational Institute on Drug Abuse (NIDA)CompletedHepatitis B | Hepatitis C | HIV | SyphilisUnited States
-
Hospital Israelita Albert EinsteinFundação de Amparo à Pesquisa do Estado de São PauloCompletedFrail Elderly SyndromeBrazil
-
King's College Hospital NHS TrustLUPUS UK; King's College Hospital CharityNot yet recruitingHydroxychloroquine Retinopathy
-
MeLSyTech, LtdRecruitingVaginal Atrophy | Postmenopausal Period | Vaginal ProlapseRussian Federation
-
Medical University of WarsawUniversity of Pecs; Polish Cardiac SocietyUnknownStable AnginaPoland, Hungary
-
LMU KlinikumRecruitingPompe Disease (Late-onset) | FSHD | Spinal Muscular Atrophy Type 3 | Inclusion Body MyositisGermany
-
Fasa University of Medical SciencesUnknownCOVID-19Iran, Islamic Republic of
-
Lewai Sharki Abdulaziz, MSc PhDAl-Kindy College of Medicine; Research & Development Directorate, Ministry...CompletedColorectal Neoplasms | Colorectal Cancer | Adenomatous Polyp of ColonIraq